Skip To Main Content
James Osborn on Muck Rack

James Osborn

As seen in: Medium, Business Wire, Investopedia, MDPI, Physical Review B, MyNorthwest.com, Optica, The Martha's Vineyard Times, PharmaTimes, techUK
I honestly think it is better to be a failure at something you love than to be a success at something you hate.... Your Online Karate Coach

Get in touch with James

Contact James, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

People-First Robotics: A Different Kind of Leadership

|
By James Osborn
| techUK
Technology and Innovation programme activities techUK bring members, industry stakeholders, and UK Government together to champion emerging technologies as an integral part of the UK economy. We help to create an environment where innovation can flourish, helping our members to build relationships, showcase their technology, and grow their business. Visit the programme page here.
Open in Who Shared View Duplicates (46) Issue with article?

OPG

|
By James Osborn
| Optica Verified
Open in Who Shared Issue with article?

LEO Pharma Announces NICE Recommendation of Reimbursement in England and Wales Original

|
By James Osborn
| Business Wire
BALLERUP, Denmark--(BUSINESS WIRE)--GLOBAL RELEASE - NOT INTENDED FOR UK MEDIA LEO Pharma, a global leader in medical dermatology, today announced that the National Institute for Health and Care Excellence (NICE) has issued Technology Appraisal Guidance (TAG) recommending the reimbursement of Anzupgo® ▼(delgocitinib) cream for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate.1 Anzupgo® ▼ is now...
Open in Who Shared View Duplicates (15) Issue with article?
See all 34 licensed articles (35 Total)